🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Metabolic Dysfunction-associated Steatohepatitis

Spleen Stiffness Measurement for the Detection of Advanced Fibrosis NCT07440511n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS The Development of MASLD Among Survivors of Breast or Colorectal Cancer NCT07280143n/a1 site📍 Bern University of Bern Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional Study NCT05974904n/a1 site📍 Chongqing Chongqing Medical University · Tests: high-sensitivity C-reactive protein to albumin ratio Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD NCT07632677n/a22 sites📍 Bengbu📍 Hefei📍 Wuhu The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… · Tests: iLivTouch (Vibration-controlled transient elastography) Digital Early Warning System for Acute Lung Injury in Liver Surgery NCT07070362n/a4 sites📍 Beijing📍 Beijing📍 Chongqing Beijing Tsinghua Chang Gung Hospital Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease NCT05332613NA1 site📍 New York Weill Medical College of Cornell University · Tests: TRE plus SOC, SOC, TRE EVOO and Metabolic Liver Health in MASLD NCT07412444NA1 site📍 Castellana Grotte Azienda Ospedaliera Specializzata in Gastroenterologia Save… · Tests: Oil Supplementation - 3 tablespoons of oil, 9 Tablespoons of Oil A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH NCT06920043Phase 230 sites📍 Chandler📍 Mesa📍 Tucson GlaxoSmithKline · Tests: Efimosfermin, Placebo Cardiac Dysfunction in Patients with Fatty Liver Disease NCT06386094n/a1 site📍 Chandigarh Post Graduate Institute of Medical Education and Research, … · Tests: Echocardiographic assessment Resmiterom Efficacy & Safety in Patients With MASH NCT07249788Phase 41 site📍 Rawalpindi Nabiqasim Industries (Pvt) Ltd · Tests: Resmetirom A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH NCT07221227Phase 391 sites📍 Chandler📍 Tucson📍 Little Rock GlaxoSmithKline · Tests: Efimosfermin alfa, Efimosfermin alfa, Placebo The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) NCT07093346NA3 sites📍 Nottingham📍 Nottingham📍 Nottingham University of Nottingham · Tests: Pectin, Cocoa Powder, Magnetic Resonance Imaging with Contrast COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study NCT06704516Phase 11 site📍 Oxford University of Oxford · Tests: Menopausal hormone therapy Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo) NCT07330830n/a3 sites📍 Cayenne📍 Pointe-à-Pitre📍 Saint-Denis Centre Hospitalier Universitaire de la Guadeloupe Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis NCT07270601NA1 site📍 Seattle ContextVision AB · Tests: Verasonics NXT Data Acquisition System, Philips EPIQ Elite, EchoSense FibroScan, Philips 3T Ingenia Elition Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes NCT06989723Phase 41 site📍 Seongnam-si Seoul National University Bundang Hospital · Tests: Pioglitazone 15 MG [Actos], Empagliflozin 10 MG [Jardiance], Empagliflozin 10 MG [Jardiance] + Pioglitazone 15 MG [Acto… A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition NCT05519475Phase 271 sites📍 Flagstaff📍 Peoria📍 Tucson Regeneron Pharmaceuticals · Tests: ALN-HSD, Placebo A Study of UBT251 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH) NCT07145151Phase 21 site📍 Beijing The United Bio-Technology (Hengqin) Co., Ltd. · Tests: UBT251, Placebo A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis NCT06461208Phase 323 sites📍 Basildon📍 Bournemouth📍 Bristol King's College London · Tests: Encapsulated FMT, Placebo High-Risk Transcriptome Molecular Prediction Study of MASH-Associated Colorectal Polyps NCT07463287n/a1 site📍 Shanghai Shanghai East Hospital Development of Microbial Therapeutics for Metabolic-associated Fatty Liver Disease: From Mechanistic Investigations to Clinical Trials NCT06873165NA1 site📍 Taipei National Taiwan University Hospital · Tests: Probiotics, Placebo A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) NCT05648214Phase 1, Phase 26 sites📍 Glendale📍 Los Angeles📍 Miami Regeneron Pharmaceuticals · Tests: ALN-PNP, Placebo (PB) Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial NCT06138821NA2 sites📍 Boston📍 Morgantown Pichamol Jirapinyo, MD, MPH · Tests: ESG + lifestyle modification, Lifestyle modification Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme NCT07658755n/a1 site📍 Madrid Hospital General Universitario Gregorio Marañon Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly NCT07068191NA1 site📍 Tyumen Phenomen Pharma · Tests: Dietary supplement "Gepaktiv", UDCA (Ursodeoxycholic acid), Ademetionine A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH) NCT07325526Phase 227 sites📍 Chandler📍 Coronado📍 La Mesa Boehringer Ingelheim · Tests: BI 3802876, Placebo A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis NCT07660848Phase 22 sites📍 Beijing📍 Zhengzhou Fujian Shengdi Pharmaceutical Co., Ltd. · Tests: HRS-4729 Injection, HRS9531 Injection, HRS-4729 Injection Placebo, HRS9531 Injection Placebo Liver Steatosis and Fibrosis in Non-Celiac Wheat Sensitivity Patients: a Prospective Study NCT07750535n/a2 sites📍 Palermo📍 Palermo University of Palermo · Tests: Prevalence and severity of liver steatosis and fibrosis, LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis NCT06632444Phase 3531 sites📍 Birmingham📍 Peoria📍 Scottsdale Boehringer Ingelheim · Tests: Survodutide, Placebo Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial NCT07193927Phase 21 site📍 Girona AB Biotics, SA · Tests: Lactiplantibacillus plantarum Probiotic Mixture, Placebo comparator containing maltodextrin
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy